
Broad access to highly accurate diagnostic testing for infectious diseases in less than 30 minutes
COVID-19 Update
Talis Awarded NIH RADx Contract to Launch Talis One™ System for Point-of-Care COVID-19 Testing and Further Strengthens Financial Position and Leadership Team
How Talis Technology
is Changing Patient Care
Infectious diseases, a global problem
Today, patients are often forced to endure days of waiting for lab results. As a result, doctors may initiate unnecessary isolation or empirical treatment based on incomplete information. This approach is costly and can be harmful to patients.
The Talis Solution
Our technology will enable doctors to rapidly select optimal treatment for their patients — providing physicians and those they treat with greater peace of mind.
COVID-19 is the first infectious disease that the Talis One System will support. Future infectious disease indications may include assays for other respiratory infections, such as influenza, as well as sexually transmitted infections (STIs) and other infections impacting women’s health.
In Development. Not currently available for sale.
The Talis Promise
To the Patient
Faster diagnosis leads to better therapy: Personalized therapies that work from day one help accelerate recovery and minimize side effects.
To the Physician
Faster results, greater confidence: Rapid innovative tests inform better treatment decisions.
To the Hospital
Better care experience that reduces cost and improves outcomes: Optimal personalized treatments reduce the length of stay.
To the Health Care System
Systemic healthcare spend is better managed: Cost-efficient, near-patient testing regardless of the care setting, from physician office to hospital bedside.